Michela Lia

609 total citations
15 papers, 328 citations indexed

About

Michela Lia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Michela Lia has authored 15 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Michela Lia's work include Pancreatic and Hepatic Oncology Research (3 papers), Sarcoma Diagnosis and Treatment (3 papers) and Pleural and Pulmonary Diseases (3 papers). Michela Lia is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Sarcoma Diagnosis and Treatment (3 papers) and Pleural and Pulmonary Diseases (3 papers). Michela Lia collaborates with scholars based in Italy, Belgium and United Kingdom. Michela Lia's co-authors include Viktor Grünwald, Robin Young, Saskia Litière, Alessandro Gronchi, Sandrine Marréaud, Tiana Raveloarivahy, Jozef Šufliarský, Sebastian Bauer, Patrick Schöffski and Bernard Escudier and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Michela Lia

15 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michela Lia Italy 9 249 147 112 70 33 15 328
Josefina Cruz Jurado Spain 9 175 0.7× 131 0.9× 103 0.9× 47 0.7× 37 1.1× 37 277
Salma Alam United Kingdom 10 160 0.6× 143 1.0× 91 0.8× 86 1.2× 53 1.6× 14 332
Maria Nirvana Formiga Brazil 12 186 0.7× 142 1.0× 118 1.1× 85 1.2× 62 1.9× 39 360
Fawaz Almutairi Saudi Arabia 7 232 0.9× 130 0.9× 68 0.6× 114 1.6× 48 1.5× 22 372
Edit Csada Hungary 7 280 1.1× 249 1.7× 153 1.4× 53 0.8× 17 0.5× 9 380
Kelly K. Curtis United States 12 146 0.6× 130 0.9× 107 1.0× 31 0.4× 110 3.3× 25 375
Ruth Pe Benito United States 8 316 1.3× 110 0.7× 108 1.0× 161 2.3× 81 2.5× 15 447
Emma Zattarin Italy 11 174 0.7× 291 2.0× 114 1.0× 120 1.7× 68 2.1× 41 500
Elisa Sottotetti Italy 11 106 0.4× 181 1.2× 101 0.9× 94 1.3× 21 0.6× 21 285

Countries citing papers authored by Michela Lia

Since Specialization
Citations

This map shows the geographic impact of Michela Lia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Lia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Lia more than expected).

Fields of papers citing papers by Michela Lia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Lia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Lia. The network helps show where Michela Lia may publish in the future.

Co-authorship network of co-authors of Michela Lia

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Lia. A scholar is included among the top collaborators of Michela Lia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Lia. Michela Lia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Magnani, Corrado, Carolina Mensi, Alessandra Binazzi, et al.. (2023). The Italian Experience in the Development of Mesothelioma Registries: A Pathway for Other Countries to Address the Negative Legacy of Asbestos. International Journal of Environmental Research and Public Health. 20(2). 936–936. 8 indexed citations
2.
Hiltbrunner, Stefanie, Laura Mannarino, Michaela B. Kirschner, et al.. (2021). Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma. Frontiers in Oncology. 11. 660039–660039. 32 indexed citations
3.
Grosso, Federica, Paola Ferro, Antonella Vigani, et al.. (2021). Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score. Diagnostics. 11(11). 2015–2015. 4 indexed citations
4.
Grosso, Federica, et al.. (2020). A feasibility exploratory study of a novel modality of using patient-reported outcomes (PROsEXPLOR) in the real world. Tumori Journal. 106(6). 464–470. 1 indexed citations
5.
Mir, Olivier, Nathan Touati, Michela Lia, et al.. (2019). Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials. Clinical Cancer Research. 25(5). 1479–1485. 64 indexed citations
6.
Péron, Julien, Sandrine Marréaud, Tiana Raveloarivahy, et al.. (2019). A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 ‘CREATE’ trial. European Journal of Cancer. 109. 192–195. 12 indexed citations
7.
Isnaldi, Edoardo, Anna Garuti, Gabriella Cirmena, et al.. (2019). Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer. Journal of Translational Medicine. 17(1). 137–137. 18 indexed citations
8.
Schöffski, Patrick, Agnieszka Woźniak, Bernard Escudier, et al.. (2018). Effect of crizotinib on disease control in patient with advanced papillary renal cell carcinoma type 1 with MET mutations or amplification: Final results of EORTC 90101 CREATE.. Journal of Clinical Oncology. 36(6_suppl). 580–580. 2 indexed citations
9.
Schöffski, Patrick, Agnieszka Woźniak, Bernard Escudier, et al.. (2017). Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial. European Journal of Cancer. 87. 147–163. 94 indexed citations
10.
Zoppoli, Gabriele, Anna Garuti, Gabriella Cirmena, et al.. (2017). Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases. Journal of Translational Medicine. 15(1). 91–91. 19 indexed citations
11.
12.
Grünwald, Viktor, Saskia Litière, Robin Young, et al.. (2016). Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma – An analysis of the EORTC 62012 study of the EORTC STBSG. European Journal of Cancer. 64. 44–51. 31 indexed citations
13.
Machiels, Jean‐Pascal, Jessica Menis, Michela Lia, et al.. (2016). Activity of afatinib administered in a window pre-operative study in squamous cell carcinoma of the head and neck (SCCHN) : EORTC-90111.. Journal of Clinical Oncology. 34(15_suppl). 6049–6049. 1 indexed citations
14.
Wagner, Dorothea, Yoon‐Koo Kang, Jolanda van Dieren, et al.. (2016). EORTC-1203: Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive stomach cancer—INNOVATION trial.. Journal of Clinical Oncology. 34(15_suppl). TPS4133–TPS4133. 4 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josefina Cruz Jurado Breakdown of academic impact, for papers by Salma Alam Breakdown of academic impact, for papers by Maria Nirvana Formiga Breakdown of academic impact, for papers by Fawaz Almutairi Breakdown of academic impact, for papers by Edit Csada Breakdown of academic impact, for papers by Kelly K. Curtis Breakdown of academic impact, for papers by Ruth Pe Benito Breakdown of academic impact, for papers by Emma Zattarin Breakdown of academic impact, for papers by Elisa Sottotetti
Rankless by CCL
2026